» Articles » PMID: 1208759

Behavioral and Neuropharmacological Analysis of Amphetamine and 2,5-dimethoxy-4-methylamphetamine in Rats

Overview
Specialty Pharmacology
Date 1975 Nov 21
PMID 1208759
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

A comparison of the behavioral pharmacology of DOM and amphetamine in rats indicated that lower doses (0.10-1.0 mg/kg) of the two agents had similar effects on schedule-controlled food-reinforced and shock-avoidance behavior. Similarities were also noted in their effects on horizontally directed motor activity when testing was preceeded by a period of acclimation. However, most doses of DOM tended to decrease unacclimated motor activity, while amphetamine increased this behavior. Neuropharmacological antagonism studies indicated that brain catecholamines (CA) and serotonin (5-HT) are involved in the behavioral effects of both DOM and amphetamine. Cinanserin, a 5-HT receptor blocker, attenuated the behavioral disruptive effects of both agents on food-reinforced responding. Cinanserin attenuated the effects of all doses of DOM and those of higher doses of amphetamine on shock avoidance. When given prior to lower doses of amphetamine, there was a greater behavioral stimulation than when amphetamine was given alone. Prior depletion of brain CA with alpha-methyltyrosine (alpha-MT) did not affect DOM induced disruption of food-reinforced responding, while alpha-MT attenuated the behavioral effects of all doses of DOM and amphetamine on shock avoidance. These data suggest that DOM and amphetamine share a similar component in their mechanism of action which depends on the availability of a releasable pool of brain CA.

Citing Articles

Neurochemical and Behavioral Effects of a New Hallucinogenic Compound 25B-NBOMe in Rats.

Wojtas A, Herian M, Skawski M, Sobocinska M, Gonzalez-Marin A, Noworyta-Sokolowska K Neurotox Res. 2020; 39(2):305-326.

PMID: 33337517 PMC: 7936972. DOI: 10.1007/s12640-020-00297-8.


Effect of Hallucinogens on Unconditioned Behavior.

Halberstadt A, Geyer M Curr Top Behav Neurosci. 2017; 36:159-199.

PMID: 28224459 PMC: 5787039. DOI: 10.1007/7854_2016_466.


Behavioral and pharmacokinetic interactions between monoamine oxidase inhibitors and the hallucinogen 5-methoxy-N,N-dimethyltryptamine.

Halberstadt A Pharmacol Biochem Behav. 2016; 143:1-10.

PMID: 26780349 PMC: 5403252. DOI: 10.1016/j.pbb.2016.01.005.


The discriminative stimulus properties of 2,5-dimethoxy-4-methylamphetamine (DOM): differentiation from amphetamine.

Silverman P, Ho B Psychopharmacology (Berl). 1980; 68(3):209-15.

PMID: 6771804 DOI: 10.1007/BF00428105.


Mescaline: excitatory effects on acoustic startle are blocked by serotonin2 antagonists.

Davis M Psychopharmacology (Berl). 1987; 93(3):286-91.

PMID: 3124159 DOI: 10.1007/BF00187244.


References
1.
Vrbanac J, Tilson H, Moore K, Rech R . Comparison of 2, 5-dimethoxy-4-methylamphetamine (DOM) and d-amphetamine for in vivo efflux of catecholamines from rat brain. Pharmacol Biochem Behav. 1975; 3(1):57-64. DOI: 10.1016/0091-3057(75)90080-5. View

2.
Tilson H, Baker T, GYLYS J . A comparison of the discriminative stimulus properties of R-2,5-dimethoxy-4-methylamphetamine (R-DOM) and S-amphetamine in the rat. Psychopharmacologia. 1975; 44(3):225-8. DOI: 10.1007/BF00428898. View

3.
Zimmerman J, Schuster C . Spaced responding in multiple DRL schedules. J Exp Anal Behav. 1962; 5:497-504. PMC: 1404205. DOI: 10.1901/jeab.1962.5-497. View

4.
Scheel-Kruger J, Hasselager E . Studies of various amphetamines, apomorphine and clonidine on body temperature and brain 5-hydroxytryptamine metabolism in rats. Psychopharmacologia. 1974; 36(3):189-202. DOI: 10.1007/BF00421801. View

5.
Swonger A, Rech R . Serotonergic and cholinergic involvement in habituation of activity and spontaneous alternation of rats in a Y maze. J Comp Physiol Psychol. 1972; 81(3):509-22. DOI: 10.1037/h0033690. View